Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma

Hepatology Research

Volumn 42, Issue 12, 2012, Pages 1187-1195

  Kobayashi, Sayo ^a   Nouso, Kazuhiro ^a   Kinugasa, Hideaki ^a   Takeuchi, Yasuto ^a   Tomoda, Takeshi ^a   Miyahara, Koji ^a   Hagihara, Hiroaki ^a   Kuwaki, Kenji ^a   Onishi, Hideki ^a   Nakamura, Shinichiro ^a   Ikeda, Fusao ^a   Miyake, Yasuhiro ^a   Shiraha, Hidenori ^a   Takaki, Akinobu ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Biomarker; Fucosylated hemopexin; Glycosylation; Hepatocellular carcinoma; Hypercarcinogenicity

Indexed keywords

ALBUMIN; FUCOSYLATED HEMOPEXIN; HEMOPEXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER TISSUE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HUMAN; JAPANESE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTHROMBIN TIME; TUMOR VOLUME;

EID: 84870257371     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01044.x     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61 (2): 69-90.
2. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15 (Suppl 4): 5-13.
3. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127 (5): 1372-80.
4. Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15 (11): 1301-14.
5. Nouso K, Kobayashi Y, Nakamura S etal. Evolution of prognostic factors in hepatocellular carcinoma in Japan. Aliment Pharmacol Ther 2010; 31 (3): 407-14.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42 (5): 1208-36.
7. Nakamura S, Nouso K, Sakaguchi K etal. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Am J Gastroenterol 2006; 101 (9): 2038-43.
8. Comunale MA, Lowman M, Long RE etal. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 2006; 5 (2): 308-15.
9. Comunale MA, Wang M, Hafner J etal. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res 2009; 8 (2): 595-602.
10. Liu X-E, Desmyter L, Gao C-F etal. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 2007; 46 (5): 1426-35.
11. Liu Y, He J, Li C etal. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J Proteome Res 2010; 9 (2): 798-805.
12. Moriwaki K. Fucosylation and gastrointestinal cancer. World. J Hepatol 2010; 2 (4): 151-61.
13. Tsutomu N, Shunsaku T, Akihiko K etal. Glycomic analyses of glycoproteins in bile and serum during Rat Hepatocarcinogenesis. J Proteome Res 2010; 9 (10): 4888-96.
14. Nakagawa T, Uozumi N, Nakano M etal. Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts. J Biol Chem 2006; 281 (40): 29797-806.
15. Wang M, Long RE, Comunale MA etal. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2009; 18 (6): 1914-21.
16. Kobayashi M, Kuroiwa T, Suda T etal. Fucosylated fraction of alpha-fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein. Hepatol Res 2007; 37 (11): 914-22.
17. Miyaaki H, Nakashima O, Kurogi M, Eguchi K, Kojiro M. Lens culinaris agglutinin-reactive α-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol 2007; 42 (12): 962-8.
18. Nouso K, Kobayashi Y, Nakamura S etal. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein. J Gastroenterol Hepatol 2011; 26 (7): 1195-200.
19. Tada T, Kumada T, Toyoda H etal. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 2005; 25 (4): 848-53.
20. Delanghe JR, Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001; 312 (1-2): 13-23.
21. Debruyne EN, Vanderschaeghe D, Van Vlierberghe H, Vanhecke A, Callewaert N, Delanghe JR. Diagnostic value of the hemopexin n-glycan profile in hepatocellular carcinoma patients. Clin Chem 2010; 56 (5): 823-31.
22. Ruhaak LR, Uh HW, Beekman M etal. Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. J Proteome Res 2011; 10: 1667-74.
23. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40 (3): 225-35.
24. Makuuchi M, Kokudo N, Arii S etal. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008; 38 (1): 37-51.
25. Colombo M. Screening and diagnosis of hepatocellular carcinoma. Liver Int 2009; 29 (Suppl 1): 143-7.
26. Amano M, Nishimura S. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry. Methods Enzymol 2010; 478: 109-25.
27. Callewaert N, Vlierberghe HV, Hecke AV, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004; 10 (4): 429-34.
28. Okuyama N, Ide Y, Nakano M etal. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 2006; 118 (11): 2803-8.
29. Noda K, Miyoshi E, Uozumi N etal. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology 1998; 28 (4): 944-52.
30. Blomme B, Van Steenkiste C, Vanhuysse J, Colle I, Callewaert N, Van Vlierberghe H. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans. Am J Physiol Gastrointest Liver Physiol 2010; 298 (5): G615-24.